Physician

Kathleen Urban Dehorn, MD

According to 2025 Medicare claims, Kathleen Dehorn, MD (NPI: 1215143797) practices ophthalmology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is RETINA SPECIALISTS OF MICHIGAN PC (NPI: 1801048699; TIN: 26-3453700) and primary practice location at 49002-0492.

Dehorn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 473 traditional Medicare patients, billed 16,659 HCPCS/CPT codes, and received $1,523,033 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 82 prescription claims across 31 beneficiaries totaling $3,041 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 10 records totaling $1,037. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $160,897 to $1,523,033. In contrast, Part D prescription costs have fallen sharply in recent years, from $10,838 to $3,041. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$921K$1.8M2015 Medicare payment: $160,897 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $920,865 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,107,594 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,779,964 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,842,105 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,605,000 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,823,913 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,626,001 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,746,315 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,523,033 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156003,166$160,897
20166495,745$920,865
20176535,856$1,107,594
20186868,658$1,779,964
20196978,146$1,842,105
20205316,656$1,605,000
20214937,061$1,823,913
20224948,601$1,626,001
202349417,171$1,746,315
202447316,659$1,523,033

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.8K$12K2015 Drug cost: $10,838 (USD; Tot_Drug_Cst)2016 Drug cost: $9,749 (USD; Tot_Drug_Cst)2017 Drug cost: $8,200 (USD; Tot_Drug_Cst)2018 Drug cost: $9,710 (USD; Tot_Drug_Cst)2019 Drug cost: $11,556 (USD; Tot_Drug_Cst)2020 Drug cost: $6,382 (USD; Tot_Drug_Cst)2021 Drug cost: $3,009 (USD; Tot_Drug_Cst)2022 Drug cost: $3,527 (USD; Tot_Drug_Cst)2023 Drug cost: $2,058 (USD; Tot_Drug_Cst)2024 Drug cost: $3,041 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153980$10,838
201654126$9,749
201752126$8,200
201851141$9,710
201958150$11,556
20202663$6,382
20213788$3,009
20223763$3,527
20233898$2,058
20243182$3,041

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1251,206$644
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6974$94
67028Injection of drug into eye2251,296$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more176224$57
92134Imaging of retina4431,597$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate291,076$1,293
Ketorolac TromethamineKetorolac Tromethamine17790$181

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$1,037Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kathleen Urban Dehorn, MD?

Tedicare shows public-source Medicare data for Kathleen Urban Dehorn, MD (NPI 1215143797), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kathleen Urban Dehorn, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kathleen Urban Dehorn, MD?

Kathleen Urban Dehorn, MD is linked to RETINA SPECIALISTS OF MICHIGAN PC (billing NPI 1801048699) in the available physician profile data.

Does Kathleen Urban Dehorn, MD have Open Payments data?

Kathleen Urban Dehorn, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.